Reactogenicity and safety of AS03B-adjuvanted H5N1 influenza vaccine in children: an open-label, one-way, crossover trial
Authors
Pope Kosalaraksa
Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand
Louise Frenette
Q&T Research, Sherbrooke, Canada
Mamadou Dramé
GSK, King of Prussia, USA
Bruce L. Innis
Vaccines Discovery and Development, GSK, King of Prussia, USA
David W Vaughn
Vaccines Discovery and Development, GSK, King of Prussia, USA
Anne Schuind
Vaccines Discovery and Development, GSK, King of Prussia, USA
Language: English
Page range: 359 - 364
Published on: Mar 21, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Related subjects:
© 2018 Patricia Izurieta, Pope Kosalaraksa, Louise Frenette, Mamadou Dramé, Bruce L. Innis, David W Vaughn, Anne Schuind, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.